CRISPR-based POC Diagnostics Market, By Product Type, By Technology Type, By Detection Method, By Application, By Country, and By Region - Global Industry Analysis, Market Size, Market Share & Forecast from 2025-2032

Description

CRISPR-based POC Diagnostics Market size was valued at US$ 505.12 Million in 2024, expanding at a CAGR of 15.85% from 2025 to 2032.

CRISPR-based point-of-care (POC) diagnostics are rapid molecular testing solutions that leverage CRISPR gene-editing enzymes for highly specific and sensitive detection of pathogens. Rising demand for decentralized, fast diagnostics in infectious disease management, particularly for respiratory and emerging diseases, is driving market growth. Opportunities lie in developing multiplexed and instrument-free assays with shorter turnaround times, essential for use in low-resource and remote healthcare settings. A prominent trend is the integration of CRISPR diagnostics with microfluidics and portable readers to enhance accuracy while improving usability. However, challenges such as regulatory complexity, scalability of manufacturing, and limited long-term clinical validation restrain widespread adoption in routine diagnostics and large-scale screening programs.

CRISPR-based POC Diagnostics Market- Market Dynamics

Increasing adoption of rapid, decentralized diagnostic testing across healthcare settings

The increasing adoption of rapid, decentralized diagnostic testing across hospitals, clinics, and remote healthcare settings is significantly driving demand for CRISPR-based point-of-care (POC) diagnostics, which play a critical role in enabling timely and accurate disease detection. As healthcare systems place greater emphasis on early diagnosis, outbreak control, and personalized treatment, providers require highly sensitive and specific testing solutions that can be deployed outside centralized laboratories. CRISPR-based POC diagnostics address this need by enabling rapid molecular detection of pathogens, genetic markers, and infectious agents at or near the patient site. The growing reliance on fast-turnaround diagnostics in emergency care, infectious disease management, and public health surveillance is accelerating adoption. In particular, the demand for portable and easy-to-use diagnostic tools in primary care and low-resource settings is pushing manufacturers to develop compact, instrument-light CRISPR platforms without compromising accuracy. Moreover, the rising frequency of infectious disease outbreaks has highlighted the importance of scalable and decentralized testing solutions, further supporting market growth. For instance, increased use of rapid molecular tests during recent global health emergencies demonstrated the value of point-of-care diagnostics in reducing diagnostic delays. Additionally, the expanding use of POC testing in screening, surveillance, and home-based care is reinforcing the need for reliable, fast, and user-friendly CRISPR-based diagnostic solutions.

CRISPR-based POC Diagnostics Market- Segmentation Analysis:

The Global CRISPR-based POC Diagnostics Market is segmented on the basis of Product Type, Technology Type, Detection Method, Application, and Region.

The market is segmented into four categories based on product type: diagnostic kits, reagents & enzymes, disposable cartridges, and assay panels. Among these, the diagnostic kits segment dominates the market due to its direct clinical applicability and ease of use in point-of-care settings. Reagents & Enzymes rank second, driven by continuous demand from assay development, customization, and repeated test usage, particularly CRISPR-associated enzymes that determine sensitivity and specificity. Disposable Cartridges follow, gaining importance due to rising emphasis on contamination-free, single-use testing formats that simplify workflows and support scalability in mass screening and remote healthcare environments. Assay Panels rank next, as their adoption is growing with demand for multiplex detection of multiple pathogens or biomarkers in a single test, though higher development complexity and regulatory requirements currently limit widespread uptake. Collectively, these segments reflect a shift toward integrated, scalable, and rapid CRISPR-based POC diagnostic solutions.

The market is categorized into four segments based on technology type: CRISPR-Cas9, CRISPR-Cas12, CRISPR-Cas13, and multiplex CRISPR systems. The CRISPR-Cas12 segment leads the market, driven by its superior sensitivity and suitability for rapid, decentralized diagnostic applications. CRISPR-Cas13 ranks second, driven by its RNA-targeting capability, making it particularly suitable for detecting RNA viruses and infectious diseases with high clinical relevance. Multiplex CRISPR Systems follow, gaining traction as demand increases for simultaneous detection of multiple pathogens or genetic targets in a single test, although assay complexity and optimization challenges currently moderate adoption. CRISPR-Cas9 ranks next, as it is more widely used in gene editing than diagnostics and lacks inherent signal amplification features, limiting its suitability for rapid POC applications. Overall, technological prioritization reflects performance, speed, and ease of integration into decentralized diagnostic platforms.

CRISPR-based POC Diagnostics Market- Geographical Insights

The CRISPR-based point-of-care (POC) diagnostics market exhibits significant regional variation in adoption and growth rates. North America currently dominates the global landscape, benefiting from advanced healthcare infrastructure, substantial R&D investment, and a strong concentration of biotechnology companies and academic research institutions, particularly in the United States, which accelerates the commercialization of CRISPR diagnostic platforms.

Europe holds the second-largest share, supported by robust public health funding, collaborative research ecosystems in countries such as Germany, the UK, and France, and increasing integration of CRISPR assays into clinical workflows.

The Asia-Pacific region is projected to experience the fastest growth rate, driven by rising healthcare expenditure, government support for biotechnology innovation, and expanding use of rapid diagnostics across China, India, Japan, and Southeast Asia.

Strategic industry developments underscore regional momentum. For instance, Indian biotech firm CrisprBits entered a strategic collaboration with Molbio Diagnostics to develop and commercialize POC CRISPR tests, enhancing accessibility in local and global markets.

CRISPR-based POC Diagnostics Market- Country Insights

Country-level dynamics in the CRISPR-based point-of-care (POC) diagnostics market reflect differing healthcare priorities, investment climates, and innovation ecosystems. The United States leads globally, driven by strong biotech R&D funding, regulatory support for novel diagnostics, and early commercialization of CRISPR platforms, resulting in significant market share and adoption in clinical settings. Europe, with countries such as Germany, the United Kingdom, and France, follows closely, supported by collaborative research networks and integration into healthcare systems seeking rapid, accurate diagnostic tools. Asia-Pacific markets, notably China, India, and Japan, are fast expanding due to rising infectious disease burdens, increased biotech investment, and growing healthcare infrastructure, positioning these nations for rapid POC CRISPR adoption.

Strategic developments include the acquisition of Sherlock Biosciences by OraSure Technologies in the US to broaden CRISPR diagnostic offerings, and a strategic collaboration between India's CrisprBits and Molbio Diagnostics to co-develop and deploy POC CRISPR tests domestically and internationally.

CRISPR-based POC Diagnostics Market- Competitive Landscape:

The competitive landscape of the CRISPR-based point-of-care (POC) diagnostics market is characterized by rapid innovation, strategic partnerships, and consolidation among key biotechnology and diagnostics firms. Leading players such as Mammoth Biosciences, OraSure Technologies (via Sherlock Biosciences), Caspr Biotech, Integrated DNA Technologies (IDT), and GenScript are actively developing and commercializing CRISPR-based diagnostic platforms that combine high sensitivity with decentralized usability. Competitive differentiation is achieved through assay performance, patent portfolios, and integration with portable devices. Market activity includes acquisitions that strengthen technological capabilities and accelerate time-to-market; notably, Sherlock Biosciences acquired Sense Bio detection to integrate instrument-free molecular test hardware with its CRISPR technology, broadening its point-of-care portfolio.

Collaborations also enhance competitiveness, such as strategic alliances between CrisprBits and Molbio Diagnostics to co-develop and distribute rapid POC tests, expanding market reach and accelerating adoption in diverse healthcare settings.

Recent Developments:

In August 2023, CrisprBits entered a strategic collaboration with Molbio Diagnostics to jointly develop and launch CRISPR-based point-of-care (POC) tests, combining CrisprBits' PathCrisp platform with Molbio's manufacturing and distribution network to deliver rapid, affordable diagnostics globally.

SCOPE OF THE REPORT

The scope of this report covers the market by its major segments, which include as follows:

GLOBAL CRISPR-BASED POC DIAGNOSTICS MARKET KEY PLAYERS- DETAILED COMPETITIVE INSIGHTS

Abbott Laboratories
Agilent Technologies
AstraZeneca
Becton, Dickinson and Company
Bio-Rad Laboratories
Caspr Biotech
Danaher Corporation
Detect Inc.
Hologic
Illumina
Lucira Health
Mammoth Biosciences
Merck KGaA
Qiagen
QuidelOrtho
Roche Diagnostics
Sherlock Biosciences
Siemens Healthineers
Thermo Fisher Scientific
Twist Bioscience
Others

GLOBAL CRISPR-BASED POC DIAGNOSTICS MARKET, BY PRODUCT TYPE- MARKET ANALYSIS, 2019 - 2032

Diagnostic Kits
Reagents & Enzymes
Disposable Cartridges
Assay Panels

GLOBAL CRISPR-BASED POC DIAGNOSTICS MARKET, BY TECHNOLOGY TYPE- MARKET ANALYSIS, 2019 - 2032

CRISPR-Cas9
CRISPR-Cas12
CRISPR-Cas13
Multiplex CRISPR Systems

GLOBAL CRISPR-BASED POC DIAGNOSTICS MARKET, BY DETECTION METHOD- MARKET ANALYSIS, 2019 - 2032

Fluorescence-Based Detection
Colorimetric Detection
Electrochemical Detection
Lateral Flow Readout

GLOBAL CRISPR-BASED POC DIAGNOSTICS MARKET, BY APPLICATION- MARKET ANALYSIS, 2019 - 2032

Infectious Disease Detection
Genetic Disorder Screening
Oncology Diagnostics
Antimicrobial Resistance Testing

GLOBAL CRISPR-BASED POC DIAGNOSTICS MARKET, BY REGION- MARKET ANALYSIS, 2019 - 2032

North America
U.S.
Canada
Europe
Germany
UK
France
Italy
Spain
The Netherlands
Sweden
Russia
Poland
Rest of Europe
Asia Pacific
China
India
Japan
South Korea
Australia
Indonesia
Thailand
Philippines
Rest of APAC
Latin America
Brazil
Mexico
Argentina
Colombia
Rest of LATAM
The Middle East and Africa
Saudi Arabia
UAE
Israel
Turkey
Algeria
Egypt
Rest of MEA

Product Code: ANV5957

1. CRISPR-based POC Diagnostics Market Overview

1.1. Study Scope
1.2. Market Estimation Years

2. Executive Summary

2.1. Market Snippet
- 2.1.1. CRISPR-based POC Diagnostics Market Snippet by Product Type
- 2.1.2. CRISPR-based POC Diagnostics Market Snippet by Technology Type
- 2.1.3. CRISPR-based POC Diagnostics Market Snippet by Detection Method
- 2.1.4. CRISPR-based POC Diagnostics Market Snippet by Application
- 2.1.5. CRISPR-based POC Diagnostics Market Snippet by Country
- 2.1.6. CRISPR-based POC Diagnostics Market Snippet by Region
2.2. Competitive Insights

3. CRISPR-based POC Diagnostics Key Market Trends

3.1. CRISPR-based POC Diagnostics Market Drivers
- 3.1.1. Impact Analysis of Market Drivers
3.2. CRISPR-based POC Diagnostics Market Restraints
- 3.2.1. Impact Analysis of Market Restraints
3.3. CRISPR-based POC Diagnostics Market Opportunities
3.4. CRISPR-based POC Diagnostics Market Future Trends

4. CRISPR-based POC Diagnostics Industry Study

4.1. PEST Analysis
4.2. Porter's Five Forces Analysis
4.3. Growth Prospect Mapping
4.4. Regulatory Framework Analysis

5. CRISPR-based POC Diagnostics Market: Impact of Escalating Geopolitical Tensions

5.1. Impact of COVID-19 Pandemic
5.2. Impact of Russia-Ukraine War
5.3. Impact of Middle East Conflicts

6. CRISPR-based POC Diagnostics Market Landscape

6.1. CRISPR-based POC Diagnostics Market Share Analysis, 2024
6.2. Breakdown Data, by Key Manufacturer
- 6.2.1. Established Players' Analysis
- 6.2.2. Emerging Players' Analysis

7. CRISPR-based POC Diagnostics Market - By Product Type

7.1. Overview
- 7.1.1. Segment Share Analysis, By Product Type, 2024 & 2032 (%)
- 7.1.2. Diagnostic Kits
- 7.1.3. Reagents & Enzymes
- 7.1.4. Disposable Cartridges
- 7.1.5. Assay Panels

8. CRISPR-based POC Diagnostics Market - By Technology Type

8.1. Overview
- 8.1.1. Segment Share Analysis, By Technology Type, 2024 & 2032 (%)
- 8.1.2. CRISPR-Cas9
- 8.1.3. CRISPR-Cas12
- 8.1.4. CRISPR-Cas13
- 8.1.5. Multiplex CRISPR Systems

9. CRISPR-based POC Diagnostics Market - By Detection Method

9.1. Overview
- 9.1.1. Segment Share Analysis, By Detection Method, 2024 & 2032 (%)
- 9.1.2. Fluorescence-Based Detection
- 9.1.3. Colorimetric Detection
- 9.1.4. Electrochemical Detection
- 9.1.5. Lateral Flow Readout

10. CRISPR-based POC Diagnostics Market - By Application

10.1. Overview
- 10.1.1. Segment Share Analysis, By Application, 2024 & 2032 (%)
- 10.1.2. Infectious Disease Detection
- 10.1.3. Genetic Disorder Screening
- 10.1.4. Oncology Diagnostics
- 10.1.5. Antimicrobial Resistance Testing

11. CRISPR-based POC Diagnostics Market- By Geography

11.1. Introduction
- 11.1.1. Segment Share Analysis, By Geography, 2024 & 2032 (%)
11.2. North America
- 11.2.1. Overview
- 11.2.2. CRISPR-based POC Diagnostics Key Manufacturers in North America
- 11.2.3. North America Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
- 11.2.4. North America Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
- 11.2.5. North America Market Size and Forecast, By Technology Type, 2019 - 2032 (US$ Million)
- 11.2.6. North America Market Size and Forecast, By Detection Method, 2019 - 2032 (US$ Million)
- 11.2.7. North America Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
- 11.2.8. U.S.
  - 11.2.8.1. Overview
  - 11.2.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 11.2.8.3. U.S. Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
  - 11.2.8.4. U.S. Market Size and Forecast, By Technology Type, 2019 - 2032 (US$ Million)
  - 11.2.8.5. U.S. Market Size and Forecast, By Detection Method, 2019 - 2032 (US$ Million)
  - 11.2.8.6. U.S. Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
- 11.2.9. Canada
  - 11.2.9.1. Overview
  - 11.2.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 11.2.9.3. Canada Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
  - 11.2.9.4. Canada Market Size and Forecast, By Technology Type, 2019 - 2032 (US$ Million)
  - 11.2.9.5. Canada Market Size and Forecast, By Detection Method, 2019 - 2032 (US$ Million)
  - 11.2.9.6. Canada Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
11.3. Europe
- 11.3.1. Overview
- 11.3.2. CRISPR-based POC Diagnostics Key Manufacturers in Europe
- 11.3.3. Europe Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
- 11.3.4. Europe Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
- 11.3.5. Europe Market Size and Forecast, By Technology Type, 2019 - 2032 (US$ Million)
- 11.3.6. Europe Market Size and Forecast, By Detection Method, 2019 - 2032 (US$ Million)
- 11.3.7. Europe Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
- 11.3.8. Germany
  - 11.3.8.1. Overview
  - 11.3.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 11.3.8.3. Germany Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
  - 11.3.8.4. Germany Market Size and Forecast, By Technology Type, 2019 - 2032 (US$ Million)
  - 11.3.8.5. Germany Market Size and Forecast, By Detection Method, 2019 - 2032 (US$ Million)
  - 11.3.8.6. Germany Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
- 11.3.9. UK
  - 11.3.9.1. Overview
  - 11.3.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 11.3.9.3. UK Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
  - 11.3.9.4. UK Market Size and Forecast, By Technology Type, 2019 - 2032 (US$ Million)
  - 11.3.9.5. UK Market Size and Forecast, By Detection Method, 2019 - 2032 (US$ Million)
  - 11.3.9.6. UK Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
- 11.3.10. France
  - 11.3.10.1. Overview
  - 11.3.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 11.3.10.3. France Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
  - 11.3.10.4. France Market Size and Forecast, By Technology Type, 2019 - 2032 (US$ Million)
  - 11.3.10.5. France Market Size and Forecast, By Detection Method, 2019 - 2032 (US$ Million)
  - 11.3.10.6. France Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
- 11.3.11. Italy
  - 11.3.11.1. Overview
  - 11.3.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 11.3.11.3. Italy Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
  - 11.3.11.4. Italy Market Size and Forecast, By Technology Type, 2019 - 2032 (US$ Million)
  - 11.3.11.5. Italy Market Size and Forecast, By Detection Method, 2019 - 2032 (US$ Million)
  - 11.3.11.6. Italy Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
- 11.3.12. Spain
  - 11.3.12.1. Overview
  - 11.3.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 11.3.12.3. Spain Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
  - 11.3.12.4. Spain Market Size and Forecast, By Technology Type, 2019 - 2032 (US$ Million)
  - 11.3.12.5. Spain Market Size and Forecast, By Detection Method, 2019 - 2032 (US$ Million)
  - 11.3.12.6. Spain Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
- 11.3.13. The Netherlands
  - 11.3.13.1. Overview
  - 11.3.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 11.3.13.3. The Netherlands Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
  - 11.3.13.4. The Netherlands Market Size and Forecast, By Technology Type, 2019 - 2032 (US$ Million)
  - 11.3.13.5. The Netherlands Market Size and Forecast, By Detection Method, 2019 - 2032 (US$ Million)
  - 11.3.13.6. The Netherlands Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
- 11.3.14. Sweden
  - 11.3.14.1. Overview
  - 11.3.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 11.3.14.3. Sweden Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
  - 11.3.14.4. Sweden Market Size and Forecast, By Technology Type, 2019 - 2032 (US$ Million)
  - 11.3.14.5. Sweden Market Size and Forecast, By Detection Method, 2019 - 2032 (US$ Million)
  - 11.3.14.6. Sweden Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
- 11.3.15. Russia
  - 11.3.15.1. Overview
  - 11.3.15.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 11.3.15.3. Russia Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
  - 11.3.15.4. Russia Market Size and Forecast, By Technology Type, 2019 - 2032 (US$ Million)
  - 11.3.15.5. Russia Market Size and Forecast, By Detection Method, 2019 - 2032 (US$ Million)
  - 11.3.15.6. Russia Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
- 11.3.16. Poland
  - 11.3.16.1. Overview
  - 11.3.16.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 11.3.16.3. Poland Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
  - 11.3.16.4. Poland Market Size and Forecast, By Technology Type, 2019 - 2032 (US$ Million)
  - 11.3.16.5. Poland Market Size and Forecast, By Detection Method, 2019 - 2032 (US$ Million)
  - 11.3.16.6. Poland Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
- 11.3.17. Rest of Europe
  - 11.3.17.1. Overview
  - 11.3.17.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 11.3.17.3. Rest of the Europe Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
  - 11.3.17.4. Rest of the Europe Market Size and Forecast, By Technology Type, 2019 - 2032 (US$ Million)
  - 11.3.17.5. Rest of the Europe Market Size and Forecast, By Detection Method, 2019 - 2032 (US$ Million)
  - 11.3.17.6. Rest of the Europe Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
11.4. Asia Pacific (APAC)
- 11.4.1. Overview
- 11.4.2. CRISPR-based POC Diagnostics Key Manufacturers in Asia Pacific
- 11.4.3. APAC Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
- 11.4.4. APAC Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
- 11.4.5. APAC Market Size and Forecast, By Technology Type, 2019 - 2032 (US$ Million)
- 11.4.6. APAC Market Size and Forecast, By Detection Method, 2019 - 2032 (US$ Million)
- 11.4.7. APAC Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
- 11.4.8. China
  - 11.4.8.1. Overview
  - 11.4.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 11.4.8.3. China Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
  - 11.4.8.4. China Market Size and Forecast, By Technology Type, 2019 - 2032 (US$ Million)
  - 11.4.8.5. China Market Size and Forecast, By Detection Method, 2019 - 2032 (US$ Million)
  - 11.4.8.6. China Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
- 11.4.9. India
  - 11.4.9.1. Overview
  - 11.4.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 11.4.9.3. India Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
  - 11.4.9.4. India Market Size and Forecast, By Technology Type, 2019 - 2032 (US$ Million)
  - 11.4.9.5. India Market Size and Forecast, By Detection Method, 2019 - 2032 (US$ Million)
  - 11.4.9.6. India Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
- 11.4.10. Japan
  - 11.4.10.1. Overview
  - 11.4.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 11.4.10.3. Japan Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
  - 11.4.10.4. Japan Market Size and Forecast, By Technology Type, 2019 - 2032 (US$ Million)
  - 11.4.10.5. Japan Market Size and Forecast, By Detection Method, 2019 - 2032 (US$ Million)
  - 11.4.10.6. Japan Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
- 11.4.11. South Korea
  - 11.4.11.1. Overview
  - 11.4.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 11.4.11.3. South Korea Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
  - 11.4.11.4. South Korea Market Size and Forecast, By Technology Type, 2019 - 2032 (US$ Million)
  - 11.4.11.5. South Korea Market Size and Forecast, By Detection Method, 2019 - 2032 (US$ Million)
  - 11.4.11.6. South Korea Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
- 11.4.12. Australia
  - 11.4.12.1. Overview
  - 11.4.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 11.4.12.3. Australia Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
  - 11.4.12.4. Australia Market Size and Forecast, By Technology Type, 2019 - 2032 (US$ Million)
  - 11.4.12.5. Australia Market Size and Forecast, By Detection Method, 2019 - 2032 (US$ Million)
  - 11.4.12.6. Australia Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
- 11.4.13. Indonesia
  - 11.4.13.1. Overview
  - 11.4.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 11.4.13.3. Indonesia Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
  - 11.4.13.4. Indonesia Market Size and Forecast, By Technology Type, 2019 - 2032 (US$ Million)
  - 11.4.13.5. Indonesia Market Size and Forecast, By Detection Method, 2019 - 2032 (US$ Million)
  - 11.4.13.6. Indonesia Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
- 11.4.14. Thailand
  - 11.4.14.1. Overview
  - 11.4.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 11.4.14.3. Thailand Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
  - 11.4.14.4. Thailand Market Size and Forecast, By Technology Type, 2019 - 2032 (US$ Million)
  - 11.4.14.5. Thailand Market Size and Forecast, By Detection Method, 2019 - 2032 (US$ Million)
  - 11.4.14.6. Thailand Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
- 11.4.15. Philippines
  - 11.4.15.1. Overview
  - 11.4.15.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 11.4.15.3. Philippines Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
  - 11.4.15.4. Philippines Market Size and Forecast, By Technology Type, 2019 - 2032 (US$ Million)
  - 11.4.15.5. Philippines Market Size and Forecast, By Detection Method, 2019 - 2032 (US$ Million)
  - 11.4.15.6. Philippines Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
- 11.4.16. Rest of APAC
  - 11.4.16.1. Overview
  - 11.4.16.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 11.4.16.3. Rest of APAC Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
  - 11.4.16.4. Rest of APAC Market Size and Forecast, By Technology Type, 2019 - 2032 (US$ Million)
  - 11.4.16.5. Rest of APAC Market Size and Forecast, By Detection Method, 2019 - 2032 (US$ Million)
  - 11.4.16.6. Rest of APAC Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
11.5. Latin America (LATAM)
- 11.5.1. Overview
- 11.5.2. CRISPR-based POC Diagnostics Key Manufacturers in Latin America
- 11.5.3. LATAM Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
- 11.5.4. LATAM Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
- 11.5.5. LATAM Market Size and Forecast, By Technology Type, 2019 - 2032 (US$ Million)
- 11.5.6. LATAM Market Size and Forecast, By Detection Method, 2019 - 2032 (US$ Million)
- 11.5.7. LATAM Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
- 11.5.8. Brazil
  - 11.5.8.1. Overview
  - 11.5.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 11.5.8.3. Brazil Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
  - 11.5.8.4. Brazil Market Size and Forecast, By Technology Type, 2019 - 2032 (US$ Million)
  - 11.5.8.5. Brazil Market Size and Forecast, By Detection Method, 2019 - 2032 (US$ Million)
  - 11.5.8.6. Brazil Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
- 11.5.9. Mexico
  - 11.5.9.1. Overview
  - 11.5.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 11.5.9.3. Mexico Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
  - 11.5.9.4. Mexico Market Size and Forecast, By Technology Type, 2019 - 2032 (US$ Million)
  - 11.5.9.5. Mexico Market Size and Forecast, By Detection Method, 2019 - 2032 (US$ Million)
  - 11.5.9.6. Mexico Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
- 11.5.10. Argentina
  - 11.5.10.1. Overview
  - 11.5.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 11.5.10.3. Argentina Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
  - 11.5.10.4. Argentina Market Size and Forecast, By Technology Type, 2019 - 2032 (US$ Million)
  - 11.5.10.5. Argentina Market Size and Forecast, By Detection Method, 2019 - 2032 (US$ Million)
  - 11.5.10.6. Argentina Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
- 11.5.11. Colombia
  - 11.5.11.1. Overview
  - 11.5.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 11.5.11.3. Colombia Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
  - 11.5.11.4. Colombia Market Size and Forecast, By Technology Type, 2019 - 2032 (US$ Million)
  - 11.5.11.5. Colombia Market Size and Forecast, By Detection Method, 2019 - 2032 (US$ Million)
  - 11.5.11.6. Colombia Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
- 11.5.12. Rest of LATAM
  - 11.5.12.1. Overview
  - 11.5.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 11.5.12.3. Rest of LATAM Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
  - 11.5.12.4. Rest of LATAM Market Size and Forecast, By Technology Type, 2019 - 2032 (US$ Million)
  - 11.5.12.5. Rest of LATAM Market Size and Forecast, By Detection Method, 2019 - 2032 (US$ Million)
  - 11.5.12.6. Rest of LATAM Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
11.6. Middle East and Africa (MEA)
- 11.6.1. Overview
- 11.6.2. CRISPR-based POC Diagnostics Key Manufacturers in Middle East and Africa
- 11.6.3. MEA Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
- 11.6.4. MEA Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
- 11.6.5. MEA Market Size and Forecast, By Technology Type, 2019 - 2032 (US$ Million)
- 11.6.6. MEA Market Size and Forecast, By Detection Method, 2019 - 2032 (US$ Million)
- 11.6.7. MEA Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
- 11.6.8. Saudi Arabia
  - 11.6.8.1. Overview
  - 11.6.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 11.6.8.3. Saudi Arabia Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
  - 11.6.8.4. Saudi Arabia Market Size and Forecast, By Technology Type, 2019 - 2032 (US$ Million)
  - 11.6.8.5. Saudi Arabia Market Size and Forecast, By Detection Method, 2019 - 2032 (US$ Million)
  - 11.6.8.6. Saudi Arabia Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
- 11.6.9. United Arab Emirates
  - 11.6.9.1. Overview
  - 11.6.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 11.6.9.3. United Arab Emirates Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
  - 11.6.9.4. United Arab Emirates Market Size and Forecast, By Technology Type, 2019 - 2032 (US$ Million)
  - 11.6.9.5. United Arab Emirates Market Size and Forecast, By Detection Method, 2019 - 2032 (US$ Million)
  - 11.6.9.6. United Arab Emirates Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
- 11.6.10. Israel
  - 11.6.10.1. Overview
  - 11.6.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 11.6.10.3. Israel Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
  - 11.6.10.4. Israel Market Size and Forecast, By Technology Type, 2019 - 2032 (US$ Million)
  - 11.6.10.5. Israel Market Size and Forecast, By Detection Method, 2019 - 2032 (US$ Million)
  - 11.6.10.6. Israel Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
- 11.6.11. Turkey
  - 11.6.11.1. Overview
  - 11.6.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 11.6.11.3. Turkey Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
  - 11.6.11.4. Turkey Market Size and Forecast, By Technology Type, 2019 - 2032 (US$ Million)
  - 11.6.11.5. Turkey Market Size and Forecast, By Detection Method, 2019 - 2032 (US$ Million)
  - 11.6.11.6. Turkey Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
- 11.6.12. Algeria
  - 11.6.12.1. Overview
  - 11.6.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 11.6.12.3. Algeria Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
  - 11.6.12.4. Algeria Market Size and Forecast, By Technology Type, 2019 - 2032 (US$ Million)
  - 11.6.12.5. Algeria Market Size and Forecast, By Detection Method, 2019 - 2032 (US$ Million)
  - 11.6.12.6. Algeria Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
- 11.6.13. Egypt
  - 11.6.13.1. Overview
  - 11.6.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 11.6.13.3. Egypt Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
  - 11.6.13.4. Egypt Market Size and Forecast, By Technology Type, 2019 - 2032 (US$ Million)
  - 11.6.13.5. Egypt Market Size and Forecast, By Detection Method, 2019 - 2032 (US$ Million)
  - 11.6.13.6. Egypt Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
- 11.6.14. Rest of MEA
  - 11.6.14.1. Overview
  - 11.6.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
  - 11.6.14.3. Rest of MEA Market Size and Forecast, By Product Type, 2019 - 2032 (US$ Million)
  - 11.6.14.4. Rest of MEA Market Size and Forecast, By Technology Type, 2019 - 2032 (US$ Million)
  - 11.6.14.5. Rest of MEA Market Size and Forecast, By Detection Method, 2019 - 2032 (US$ Million)
  - 11.6.14.6. Rest of MEA Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)

12. Key Vendor Analysis- CRISPR-based POC Diagnostics Industry

12.1. Competitive Dashboard
- 12.1.1. Competitive Benchmarking
- 12.1.2. Competitive Positioning
12.2. Company Profiles
- 12.2.1. Abbott Laboratories
- 12.2.2. Agilent Technologies
- 12.2.3. AstraZeneca
- 12.2.4. Becton, Dickinson and Company
- 12.2.5. Bio-Rad Laboratories
- 12.2.6. Caspr Biotech
- 12.2.7. Danaher Corporation
- 12.2.8. Detect Inc.
- 12.2.9. Hologic
- 12.2.10. Illumina
- 12.2.11. Lucira Health
- 12.2.12. Mammoth Biosciences
- 12.2.13. Merck KGaA
- 12.2.14. Qiagen
- 12.2.15. QuidelOrtho
- 12.2.16. Roche Diagnostics
- 12.2.17. Sherlock Biosciences
- 12.2.18. Siemens Healthineers
- 12.2.19. Thermo Fisher Scientific
- 12.2.20. Twist Bioscience
- 12.2.21. Others

13. 360 Degree Analyst View

14. Appendix

14.1. Research Methodology
14.2. References
14.3. Abbreviations
14.4. Disclaimer
14.5. Contact Us